Zealand Pharma A/S
ZEAL.COHealthcare · Biotechnology · DK229.40DKK+0.92%
StratDeckZealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
Price · Past year
Loading chart…
Checks
- Fail: Price trending down The figures
- Fail: Sales growing slower than its peers The figures
- Pass: More profitable than similar companies The figures
- Pass: Analysts rate it a buy The figures
- Pass: Cheaper than similar companies The figures
- Pass: Beat profit forecasts The figures
Share
Keep researching
Where next from ZEAL.CO
Other stocks you may like
Fundamentals
Yahoo FinanceShowHide
What's happening?
ZEAL.CO is lagging Healthcare this month The figures
- 1D
- +0.92%
- 7D
- -3.21%
- 1M
- -17.24%
- 3M
- -23.15%
- 6M
- -27.17%
- YTD
- -50.81%
What is the market expecting?
StratDeckCheaper than similar companies, and analysts expect the price to rise The figures
Value score vs Healthcare peers
57- Fwd P/E30.48
- P/B0.9100
- P/E5.998
- Rev growth-50.6%0
Not scored on Yield. The rest were reweighted to make up the difference.
Is the business delivering?
Sales are shrinking, and profit per share is down The figures
Earnings by quarter
Latest quarter 3.92B · +4.31B on the quarter before · -3.66B on a year earlier
- 7.57BAug25—
- -404MNov25-7.98B
- -379MFeb26+25.1M
- -394MMay26-14.9M
- 3.92BAug26+4.31B
Yahoo serves only the most recent statements; EPS goes back further.
How does it compare?
Nearest in Healthcare on valueStratDeckZEAL.CO is better value than most Healthcare stocks The figures
What happens next?
Reports next on 12 Nov, in 26 days
Daily market updates
Get the brief
Get an interesting stock pick, updates on the AI sector, information on the biggest movers of the day, and more, in the Monday, Wednesday and Friday email.